Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Vickers

Showing results (341-350 of 359) with videos related to

Pageof 36
Sort By:
The Journal of Clinical Investigation|March 3, 2006
Prelamin A and lamin A appear to be dispensable in the nuclear laminaLoren G Fong, Jennifer K Ng, Jan Lammerding, et al.
European Journal of Human Genetics : EJHG|April 21, 2001
Monosomy for the most telomeric, gene-rich region of the short arm of human chromosome 16 causes minimal phenotypic effectsS W Horsley, R J Daniels, E Anguita, et al.
Frontiers in Immunology|July 16, 2024
EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulationRachel S Cooper, Catherine Sutherland, Linda M Smith, et al.
Journal of Medicinal Chemistry|April 28, 2010
Peptide nucleic acids conjugated to short basic peptides show improved pharmacokinetics and antisense activity in adipose tissueEdward V Wancewicz, Martin A Maier, Andrew M Siwkowski, et al.
Harm Reduction Journal|May 19, 2026
A mixed methods examination of organizational approaches to fentanyl test strip distribution and training across multiple statesKitty H Gelberg, Megan E Hall, Janet E Childerhose, et al.
The Journal of Experimental Medicine|April 15, 2015
Biomechanical forces promote blood development through prostaglandin E2 and the cAMP-PKA signaling axisMiguel F Diaz, Nan Li, Hyun Jung Lee, et al.
Biorxiv : the Preprint Server for Biology|November 25, 2020
The Development of a Novel Nanobody Therapeutic for SARS-CoV-2Gang Ye, Joseph P Gallant, Christopher Massey, et al.
Nature Biotechnology|May 1, 2019
Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic indexWen Shen, Cheryl L De Hoyos, Michael T Migawa, et al.
Nucleic Acids Research|August 21, 2021
Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotidesBrooke A Anderson, Graeme C Freestone, Audrey Low, et al.
Anesthesia and Analgesia|December 1, 2017
Opioid Prescribing for the Treatment of Acute Pain in Children on Hospital DischargeConstance L Monitto, Aaron Hsu, Shuna Gao, et al.
Pageof 36

Showing results (341-350 of 359) with videos related to

Sort By:
Pageof 36
The Journal of Clinical Investigation|March 3, 2006
Prelamin A and lamin A appear to be dispensable in the nuclear laminaLoren G Fong, Jennifer K Ng, Jan Lammerding, et al.
European Journal of Human Genetics : EJHG|April 21, 2001
Monosomy for the most telomeric, gene-rich region of the short arm of human chromosome 16 causes minimal phenotypic effectsS W Horsley, R J Daniels, E Anguita, et al.
Frontiers in Immunology|July 16, 2024
EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulationRachel S Cooper, Catherine Sutherland, Linda M Smith, et al.
Journal of Medicinal Chemistry|April 28, 2010
Peptide nucleic acids conjugated to short basic peptides show improved pharmacokinetics and antisense activity in adipose tissueEdward V Wancewicz, Martin A Maier, Andrew M Siwkowski, et al.
Harm Reduction Journal|May 19, 2026
A mixed methods examination of organizational approaches to fentanyl test strip distribution and training across multiple statesKitty H Gelberg, Megan E Hall, Janet E Childerhose, et al.
The Journal of Experimental Medicine|April 15, 2015
Biomechanical forces promote blood development through prostaglandin E2 and the cAMP-PKA signaling axisMiguel F Diaz, Nan Li, Hyun Jung Lee, et al.
Biorxiv : the Preprint Server for Biology|November 25, 2020
The Development of a Novel Nanobody Therapeutic for SARS-CoV-2Gang Ye, Joseph P Gallant, Christopher Massey, et al.
Nature Biotechnology|May 1, 2019
Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic indexWen Shen, Cheryl L De Hoyos, Michael T Migawa, et al.
Nucleic Acids Research|August 21, 2021
Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotidesBrooke A Anderson, Graeme C Freestone, Audrey Low, et al.
Anesthesia and Analgesia|December 1, 2017
Opioid Prescribing for the Treatment of Acute Pain in Children on Hospital DischargeConstance L Monitto, Aaron Hsu, Shuna Gao, et al.
Pageof 36